Invitae
San Francisco, US · Delaware corporation · 669 employees on LinkedIn · 8 known investors
Find your way into Invitae
28 people in our graph share verified history with the Invitae team — schools, employers, funds. One of them is your warm intro.
Mudit K. Jainunlockedknows Shelly Guyer · together at Irhythmtech (overlapped)
×6knows the team · via Irhythmtech
×4knows the team · via Invitae
knows the team · via Nuvelo
Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Founders & leadership
SG
Sean GeorgeinCo-Founder and CEO2010–2022
RS
Randal ScottCo-founder
SG
Shelly GuyerinChief Sustainability Officer2021–2022
LB
Lee BendekgeyinExecutive
GC
Geoffrey CrouseNamed on SEC filing
Board
EA
CG
Christine GorjancBoard director
Investors · 8
Reported raises · per SEC filings
Form D private placements$167.6M disclosed across 5 rounds · 2017–2020
▶$19.7MraisedApr 2020 · 5 investors · BiotechnologyRule 506(b)
▶$19.7MraisedApr 2020 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shelly GuyerExecutive Officer
- Christine GorjancDirector
- Chitra NayakDirector
- Eric AguiarDirector
- Sean GeorgeExecutive Officer, Director
- Lee BendekgeyExecutive Officer
- Geoffrey CrouseDirector
- Offering amount
- $19.7M
- Amount sold
- $19.7M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$52.4MraisedApr 2020 · 58 investors · BiotechnologyRule 506(b)
▶$52.4MraisedApr 2020 · 58 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Geoffrey CrouseDirector
- Sean GeorgeExecutive Officer, Director
- Christine GorjancDirector
- Chitra NayakDirector
- Eric AguiarDirector
- Shelly GuyerExecutive Officer
- Lee BendekgeyExecutive Officer
- Offering amount
- $52.4M
- Amount sold
- $52.4M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$73.5MraisedAug 2017 · 23 investors · BiotechnologyRule 506(b)
▶$73.5MraisedAug 2017 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shelly GuyerExecutive Officer
- Lee BendekgeyExecutive Officer
- Randal ScottExecutive Officer, Director
- Christine GorjancDirector
- Eric AguiarDirector
- Geoffrey CrouseDirector
- Sean GeorgeExecutive Officer, Director
- Offering amount
- $73.5M
- Amount sold
- $73.5M
- Sales commissions
- $4.4M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.1MraisedAug 2017 · 12 investors · BiotechnologyRule 506(b)
▶$16.1MraisedAug 2017 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Randal ScottExecutive Officer, Director
- Lee BendekgeyExecutive Officer
- Shelly GuyerExecutive Officer
- Sean GeorgeExecutive Officer, Director
- Geoffrey CrouseDirector
- Eric AguiarDirector
- Christine GorjancDirector
- Offering amount
- $16.1M
- Amount sold
- $16.1M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedJun 2017 · 22 investors · BiotechnologyRule 506(b)
▶$6MraisedJun 2017 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shelly GuyerExecutive Officer
- Eric AguiarDirector
- Sean GeorgeExecutive Officer, Director
- Christine GorjancDirector
- Geoffrey CrouseDirector
- Lee BendekgeyExecutive Officer
- Randal ScottExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
The Invitae mafia →10 people who came through Invitae went on to found or lead other companies.
Guy SnirProduct LeadFounded Nest Genomics +1Kyle LefkoffBoard Member and Lead Venture Capital InvestorFounded ArraybiopharmaNick GreenfieldHead of MicrobiomeFounded One CodexCole BransfordData EngineerFounded ZageVinay Datta PinnakaSenior Software EngineerFounded loopfourAndrew ShinoharaDirector of Engineering, DataFounded Tokaido HealthPatrick ShortBioinformatician (Contract)Founded Sano GeneticsFarid VijPresident & GM, Patient Network and DataFounded CiitizenNasha FitterVP, RWE and Ciitizen PlatformFounded CiitizenRuby GadelrabMarketing and Commerical DevelopmentFounded MDisrupt
Competitors · 4
by search overlapLabcorp3759 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Quest Diagnostics2645 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Sequencing1670 shared keywordsSequencing.com offers free storage of personal DNA data along with tools and reports that turn genetic testing results into health-related insights for consumers. The company addresses data storage, usability, and privacy challenges created by widely available consumer genetic testing.
Myriad1463 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Companies competing with Invitae for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 3
Early investors' stakes continue via these dealsClear Genetics
Gia is an AI-powered chatbot designed to help patients and doctors with genetic testing workflows, including risk assessment, family history collection, and results delivery. It serves cancer patients and those at increased risk for cancer in the United States.
Jungla
Jungla was a San Francisco genomics startup that built a cloud-based platform combining machine learning, functional genomics, and biophysics to interpret ambiguous genetic variants for clinicians and patients.
Singular Bio
Genetic screening platform for early pregnancy, acquired by Invitae.
In the news
Frequently asked questions
- What does Invitae do?
- Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
- Who founded Invitae?
- Invitae was founded by Sean George, Randal Scott.
- Who are Invitae's investors?
- Invitae's investors include Civilization Ventures Management, Llc, Decheng Capital, Fifty Years, Manta Ray Ventures, Oberland Capital, Prefix Capital, Tech Wildcatters, Aisling Capital.
- How much funding has Invitae raised?
- Invitae has disclosed $167.6M raised across 5 rounds.
- Where is Invitae headquartered?
- Invitae is headquartered in San Francisco, US.